The RhoC Transgenic Mouse as a Realistic Model of Inflammatory Breast Cancer

Abstract

Inflammatory breast cancer is a unique and highly aggressive form of locally advanced breast cancer. Although it effects a small proportion of women with breast cancer annually in the United States (approximately 6%), it carries with it the worst prognosis of all breast cancers. Inflammatory breast cancer is unique in the aspect that it invades and grows within the dermal lymphatics of the breast. Blockage of the dermal lymphatics by tumor emboli leads to edema and swelling of the breast, thus giving the appearance of inflammation. The tumor emboli can also metastasize via the dermal lymphatics to the skin of the contralateral breast, chest and stomach.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2002
Accession Number
ADA411463

Entities

People

  • Kenneth L. Van Golen

Organizations

  • University of Michigan

Tags

DTIC Thesaurus Topics

  • Anti-Bacterial Agents
  • Biomedical Research
  • Breast Cancer
  • Cancer
  • Carrier Proteins
  • Cell Line
  • Cells
  • Demographic Cohorts
  • Diseases And Disorders
  • Epithelial Cells
  • Genes
  • Michigan
  • Neoplasms
  • Stem Cells
  • Tissue Culture
  • Tissue Culture Cells
  • United States

Fields of Study

  • Medicine

Readers

  • Molecular and Cellular Biology
  • Oncology
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.